Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development

Carcinogenesis

Volumn 22, Issue 12, 2001, Pages 2001-2004

  Kawamori, Toshihiko ^a   Uchiya, Naoaki ^a   Nakatsugi, Seiichi ^a   Watanabe, Kouji ^a   Ohuchida, Shuichi ^b   Yamamoto, Hiroshi ^b   Maruyama, Takayuki ^b   Kondo, Kigen ^b   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b ONO PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 6 [3 (4 CHLORO 2 METHYLPHENYLSULFONYLAMINOMETHYL)BICYCLO[2.2.2]OCTAN 2 YL] 5 HEXENOIC ACID; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPSY; BREAST CANCER; CANCER INCIDENCE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET; DRUG SELECTIVITY; DRUG STRUCTURE; FEEDING; FEMALE; HISTOPATHOLOGY; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

EID: 0035687873     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.12.2001     Document Type: Article

References (30)

1. Global breast cancer mortality statistics
2. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer
3. Nonsteroidal antiinflammatory drugs and breast cancer
4. Transcription of cyclo-oxygenase-2 is enhanced in transformed mammary epithelial cells
5. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
6. Chemo-prevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor
7. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats
8. Chemo-preventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
9. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice
10. Cyclooxygenase-2 gene expression in human breast cancer
11. Prostaglandins and breast cancer
12. Breast cancer, prostaglandins and patient survival
13. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
14. Studies of prostaglandins in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene
15. Prostaglandin E2 receptor heterogeneity and dysfunction in mammary tumor cells
16. Role of the prostaglandin E2 receptor in mammary tumor metastasis
17. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene
18. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis
19. Some perspectives on the nutritional aspects of breast cancer research. Food-derived heterocyclic amines as etiologic agents in human mammary cancer
20. Well-done meat intake and the risk of breast cancer
21. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat and breast cancer risk
22. Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones
23. Influence of the Walker 256 carcinosarcoma on muscle, tumor and whole-body protein synthesis and growth rate in the cancer-bearing rat
24. Tumours of the mammary gland
25. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level
26. Suppression of prostaglandin E receptor signaling by the variant form of EP1 subtype
27. The nucleotide sequence of the rat cytoplasmic beta-actin gene
28. The biochemistry of cell death by apoptosis
29. A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA
30. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice